Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A Single-Arm, Open-Label, Interventional Study to Evaluate the Efficacy of HS-IT101 Autologous Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy After Lymphodepleting Preconditioning with Fludarabine and Cyclophosphamide and Subsequent Interleukin-2 Therapy in Patients with Advanced Renal Cancer.
Epistemonikos ID: 1b451aa1ba1c8697605575a3cf05d79dce1afa60
First added on: Aug 19, 2026